World Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.63M Sell
59,911
-4,560
-7% -$266K 0.06% 332
2025
Q4
$3.48M Buy
64,471
+7,977
+14% +$384K 0.06% 337
2025
Q3
$2.55M Buy
56,494
+1,821
+3% +$85K 0.05% 355
2025
Q2
$2.53M Sell
54,673
-4,206
-7% -$206K 0.06% 335
2025
Q1
$3.59M Buy
58,879
+3,190
+6% +$186K 0.09% 255
2024
Q4
$3.15M Buy
55,689
+11,583
+26% +$647K 0.09% 263
2024
Q3
$2.28M Buy
44,106
+6,954
+19% +$326K 0.07% 277
2024
Q2
$1.54M Buy
37,152
+33,794
+1,006% +$1.51M 0.1% 188
2024
Q1
$220K Sell
3,358
-1,610
-32% -$82K 0.03% 364
2023
Q4
$255K Buy
+4,968
New +$261K 0.03% 332

Other funds holding BMY

World Investment Advisors's BMY Position: Q1 2026 in Review

World Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 7.1% in Q1 2026, selling an estimated $266K and leaving 59,911 shares worth $3.63M. The position accounts for 0.06% of the portfolio, ranked #332.

World Investment Advisors first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • World Investment Advisors held 59,911 shares of Bristol-Myers Squibb worth $3.63M as of Q1 2026.
  • World Investment Advisors sold 4,560 Bristol-Myers Squibb shares in Q1 2026, an estimated $266K.
  • Bristol-Myers Squibb made up 0.06% of World Investment Advisors's portfolio in Q1 2026, its #332 holding.
  • World Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on World Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.